N-(1-(2-(4-ETHYL-5-OXO-4,5-DIHYDRO-1H-TETRAZOL-1-YL)ETHYL)-4-(METHOXYMETHYL)PIPERIDIN-4-YL)-N-PHENYLBUTANAMIDE
UNII LS328ESZ94
Substance Identification & Data
This profile provides standardized clinical and technical data for N-(1-(2-(4-ethyl-5-oxo-4,5-dihydro-1h-tetrazol-1-yl)ethyl)-4-(methoxymethyl)piperidin-4-yl)-n-phenylbutanamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LS328ESZ94.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C22H34N6O3 OPUPOXAJQLJLJP-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-(1-(2-(4-ethyl-5-oxo-4,5-dihydro-1h-tetrazol-1-yl)ethyl)-4-(methoxymethyl)piperidin-4-yl)-n-phenylbutanamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.